Pipazetate or pipazethate
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162651This classification denotes an antitussive agent with the molecular formula C21H25N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M5EK1T5V2L, chemically known as 10h-pyrido(3,2-b)(1,4)benzothiazine-10-carboxylic acid, 2-(2-piperidinoethoxy)ethyl ester but more generally known as pipazetate, which bears US NIH Compound Identifier 22425. European Medicines Agency schedules Pipazetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09861MIG. The term PIPAZETATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). World Health Organization schedules pipazetate in its Anatomical Therapeutic Chemical (ATC) Classification. PIPAZETATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Pipazetate or pipazethate bears US NLM identifiers UMLS ID C0071099 and NCI Concept Code C82252. SMILES: C1CCN(CC1)CCOCCOC(=O)N2C3=CC=CC=C3SC4=C2N=CC=C4.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.